Saturday, October 11, 2025 10:09:55 AM
Nice straw man rebuttal. FDA doesn't need or want a statistically valid controlled and monitored human demonstration that Radiogel works and works safely. They need that valid demonstration with animals to consider human trials, and to date, in over two decades, no one has made anything close to such a demonstration. Without that, Radiogel ain't going anywhere anytime soon. MK's bogus safety conclusions based on sub-clinical doses in rabbits is junk science at it's finest. What was FDA supposed to do with such nonsense?
Time will tell if a valid human demonstration in India can make up for the lack of an animal demonstration, but that has to be with same formulation they intend to trial in USA for FDA to consider the data. That is impossible without operations in India manufacturing Radiogel to FDA standards, which seems at least two years away. Going this far more expensive and lengthy route in India makes no sense, unless that second set of never published rabbit results at JHU were a disaster, and RDGL is just a bogus stock selling scam for MK to live the high life in his remaining years.
Gotta feel bad for the bag holders
Time will tell if a valid human demonstration in India can make up for the lack of an animal demonstration, but that has to be with same formulation they intend to trial in USA for FDA to consider the data. That is impossible without operations in India manufacturing Radiogel to FDA standards, which seems at least two years away. Going this far more expensive and lengthy route in India makes no sense, unless that second set of never published rabbit results at JHU were a disaster, and RDGL is just a bogus stock selling scam for MK to live the high life in his remaining years.
Gotta feel bad for the bag holders
Recent RDGL News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2025 09:14:29 PM
